• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重慢性移植物抗宿主病的特征是相对于中枢记忆细胞,效应记忆CD4(+)细胞占优势。

Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells.

作者信息

Yamashita Kouhei, Choi Uimook, Woltz Patricia C, Foster Susan F, Sneller Michael C, Hakim Francis T, Fowler Daniel H, Bishop Michael R, Pavletic Steven Z, Tamari Marisa, Castro Kathleen, Barrett A John, Childs Richard W, Illei Gabor G, Leitman Susan F, Malech Harry L, Horwitz Mitchell E

机构信息

Laboratory of Host Defenses, National Institutes of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD 20892-1886, USA.

出版信息

Blood. 2004 May 15;103(10):3986-8. doi: 10.1182/blood-2003-09-3286. Epub 2004 Feb 5.

DOI:10.1182/blood-2003-09-3286
PMID:14764530
Abstract

Donor alloreactive CD4(+) T cells are important to the pathogenesis of chronic graft-versus-host disease (cGVHD), but specific subsets of CD4(+) T cells responsible for GVHD have not been defined. We hypothesized that cGVHD might be associated with a preponderance of CD4(+) effector memory cells (CCR7(-)/CD62L(low), CD4(EM)). We analyzed CCR7 and CD62L expression on CD4(+) T cells from stem cell transplantation patients, who did or did not develop cGVHD, and healthy donors. Patients with cGVHD had a higher percentage of CD4(EM) cells (35.5% +/- 2.9%) than healthy donors (13.8% +/- 0.7%; P <.0001) or patients without cGVHD that received a transplant (21.7% +/- 2.1%; P <.01). Using corticosteroid dose as a surrogate marker for cGVHD severity, severe cGVHD was associated with a higher percentage of CD4(EM) cells. The proportion of CD4(EM) cells in corticosteroid-dependent patients with systemic lupus erythematosis or Wegener granulomatosis did not differ from patients without cGVHD that received a transplant. This finding implies that overrepresentation of CD4(EM) cells is a unique feature of cGVHD.

摘要

供体同种异体反应性CD4(+) T细胞对慢性移植物抗宿主病(cGVHD)的发病机制很重要,但负责移植物抗宿主病的CD4(+) T细胞的特定亚群尚未明确。我们推测cGVHD可能与CD4(+)效应记忆细胞(CCR7(-)/CD62L(低),CD4(EM))占优势有关。我们分析了干细胞移植患者(无论是否发生cGVHD)以及健康供体的CD4(+) T细胞上CCR7和CD62L的表达。发生cGVHD的患者中CD4(EM)细胞的百分比(35.5% +/- 2.9%)高于健康供体(13.8% +/- 0.7%;P <.0001)或未发生cGVHD的移植患者(21.7% +/- 2.1%;P <.01)。使用皮质类固醇剂量作为cGVHD严重程度的替代标志物,重度cGVHD与更高百分比的CD4(EM)细胞相关。患有系统性红斑狼疮或韦格纳肉芽肿病的皮质类固醇依赖患者中CD4(EM)细胞的比例与未发生cGVHD的移植患者没有差异。这一发现表明CD4(EM)细胞的过度存在是cGVHD的一个独特特征。

相似文献

1
Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells.严重慢性移植物抗宿主病的特征是相对于中枢记忆细胞,效应记忆CD4(+)细胞占优势。
Blood. 2004 May 15;103(10):3986-8. doi: 10.1182/blood-2003-09-3286. Epub 2004 Feb 5.
2
Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.幼稚和干细胞记忆 T 细胞亚群的恢复揭示了慢性移植物抗宿主病中 CD4 和 CD8 T 细胞重建的相反模式。
Front Immunol. 2019 Mar 6;10:334. doi: 10.3389/fimmu.2019.00334. eCollection 2019.
3
Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.与慢性移植物抗宿主病相关的CD4(+)和CD8(+)中央记忆细胞的独特异常在体外光化学疗法后得到改善。
Biol Blood Marrow Transplant. 2006 Jan;12(1 Suppl 2):22-30. doi: 10.1016/j.bbmt.2005.11.004.
4
Altered homeostasis of CD4(+) memory T cells in allogeneic hematopoietic stem cell transplant recipients: chronic graft-versus-host disease enhances T cell differentiation and exhausts central memory T cell pool.异基因造血干细胞移植受者中CD4(+)记忆T细胞的稳态改变:慢性移植物抗宿主病增强T细胞分化并耗尽中枢记忆T细胞库。
Biol Blood Marrow Transplant. 2007 Oct;13(10):1176-84. doi: 10.1016/j.bbmt.2007.06.009. Epub 2007 Aug 3.
5
Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells.供体T细胞迁移和启动部位对幼稚型和记忆表型CD4 T细胞诱导移植物抗宿主病的影响。
Blood. 2008 May 15;111(10):5242-51. doi: 10.1182/blood-2007-09-107953. Epub 2008 Feb 19.
6
[The impact of donor naive and memory T cell subsets on patient outcome following allogeneic stem cell transplantation: relationship between infused donor CD4+/CCR7+ T cell subsets and acute graft-versus-host disease].[供体初始和记忆性T细胞亚群对异基因干细胞移植后患者预后的影响:输注的供体CD4+/CCR7+T细胞亚群与急性移植物抗宿主病的关系]
Pathol Biol (Paris). 2014 Jun;62(3):123-8. doi: 10.1016/j.patbio.2014.02.013. Epub 2014 Jun 3.
7
Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells.慢性移植物抗宿主病与外周血CD4+CD25高表达调节性T细胞数量增加有关。
Blood. 2004 Mar 15;103(6):2410-6. doi: 10.1182/blood-2003-06-2073. Epub 2003 Nov 6.
8
Comparative analysis of naïve and memory CD4+ and CD8+ T-cell subsets in bone marrow and G-CSF-mobilized peripheral blood stem cell allografts: impact of donor characteristics.骨髓和粒细胞集落刺激因子动员的外周血干细胞同种异体移植物中初始和记忆性CD4+及CD8+ T细胞亚群的比较分析:供体特征的影响
Exp Hematol. 2007 Jun;35(6):861-71. doi: 10.1016/j.exphem.2007.03.006.
9
A high migratory capacity of donor T-cells in response to the lymph node homing receptor CCR7 increases the incidence and severity of GvHD.供体T细胞对淋巴结归巢受体CCR7产生的高迁移能力会增加移植物抗宿主病(GvHD)的发生率和严重程度。
Bone Marrow Transplant. 2017 May;52(5):745-752. doi: 10.1038/bmt.2016.342. Epub 2017 Jan 23.
10
Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.B细胞和T细胞免疫重建改变先于慢性移植物抗宿主病临床症状出现,并受发病类型影响。
Ann Hematol. 2017 Feb;96(2):299-310. doi: 10.1007/s00277-016-2881-x. Epub 2016 Dec 9.

引用本文的文献

1
Therapeutic Potential of a Senolytic Approach in a Murine Model of Chronic GVHD.衰老细胞溶解疗法在慢性移植物抗宿主病小鼠模型中的治疗潜力
Biology (Basel). 2023 Apr 25;12(5):647. doi: 10.3390/biology12050647.
2
Noninvasive Imaging of CD4+ T Cells in Humanized Mice.在人源化小鼠中进行 CD4+ T 细胞的非侵入性成像。
Mol Cancer Ther. 2022 Apr 1;21(4):658-666. doi: 10.1158/1535-7163.MCT-21-0888.
3
Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients.基于免疫重建的慢性移植物抗宿主病患者风险分层评分
Front Oncol. 2021 Jul 22;11:705568. doi: 10.3389/fonc.2021.705568. eCollection 2021.
4
A distinct glycerophospholipid metabolism signature of acute graft versus host disease with predictive value.急性移植物抗宿主病具有预测价值的独特甘油磷脂代谢特征。
JCI Insight. 2019 Jul 25;5(16):129494. doi: 10.1172/jci.insight.129494.
5
Inducible T-Cell Co-Stimulator Impacts Chronic Graft-Versus-Host Disease by Regulating Both Pathogenic and Regulatory T Cells.可诱导性T细胞共刺激分子通过调节致病性T细胞和调节性T细胞影响慢性移植物抗宿主病。
Front Immunol. 2018 Jun 22;9:1461. doi: 10.3389/fimmu.2018.01461. eCollection 2018.
6
B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.用于预测异基因造血干细胞移植后急性/慢性移植物抗宿主病的体液中基于B细胞的可溶性生物标志物
Front Immunol. 2017 Jan 16;7:660. doi: 10.3389/fimmu.2016.00660. eCollection 2016.
7
The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview.动物模型在造血干细胞移植和移植物抗宿主病研究中的作用:历史概述
Front Immunol. 2016 Aug 30;7:333. doi: 10.3389/fimmu.2016.00333. eCollection 2016.
8
IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation.白细胞介素-10阳性调节性B细胞在脐带血中富集,可能对脐带血移植后的慢性移植物抗宿主病起到保护作用。
Blood. 2016 Sep 8;128(10):1346-61. doi: 10.1182/blood-2016-01-695122. Epub 2016 Jul 20.
9
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.美国国立卫生研究院慢性移植物抗宿主病临床试验标准共识发展项目:III. 2014年生物标志物工作组报告。
Biol Blood Marrow Transplant. 2015 May;21(5):780-92. doi: 10.1016/j.bbmt.2015.01.003. Epub 2015 Jan 30.
10
Treatment of severe chronic graft-versus-host disease with decidual stromal cells and tracing with (111)indium radiolabeling.用蜕膜基质细胞治疗严重慢性移植物抗宿主病并进行(111)铟放射性标记追踪
Stem Cells Dev. 2015 Jan 15;24(2):253-63. doi: 10.1089/scd.2014.0265.